ScholarIQanswers from OpenAlex

Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer

PaperCitations, authors & open-access status

Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer have?

ScholarIQcitation count

Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer has 289 citations in the OpenAlex counts ScholarIQ stores.

When was Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer published?

ScholarIQyear

Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer has 2020 year in the ScholarIQ index.

What is the open-access status of Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer?

ScholarIQoa status

Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer has closed oa status in the ScholarIQ index.

What is the DOI of Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer?

ScholarIQdoi

The DOI for Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer is on the source record.

What is the PMID of Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer?

ScholarIQpmid

The PMID for Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer is on the source record.

What is the OpenAlex record for Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer?

ScholarIQopenalex

The OpenAlex for Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i> -mutated non–small cell lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial